Loading clinical trials...
Loading clinical trials...
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy in Patients With Advanced Pancreatic Cancer: a Prospective, Observational Pilot Study
Conditions
Interventions
Tumor DNA circulating in the bloodstream (circulating tumor DNA; ctDNA)
Locations
1
United States
Zuckerberg Cancer Center
New Hyde Park, New York, United States
Start Date
May 22, 2023
Primary Completion Date
October 17, 2023
Completion Date
September 1, 2025
Last Updated
August 14, 2025
NCT07409272
NCT05065801
NCT04605913
NCT06662006
NCT07296341
NCT06361888
Lead Sponsor
Northwell Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions